Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.

Sangamo Therapeutics, Inc.

Sangamo Therapeutics, Inc. develops genomic cures for patients suffering from severe diseases using proprietary zinc finger technology.

COM:SANGAMO

Sangamo Therapeutics, Inc.

Last Close

1.96

22/11 15:29

Market Cap

408.95M

Beta: -

Volume Today

942.09K

Avg: -

Financials Not Available